BACE2
Basic information
Region (hg38): 21:41167801-41282530
Previous symbols: [ "AEPLC" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BACE2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 26 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 3 | |||||
Total | 0 | 0 | 26 | 8 | 5 |
Variants in BACE2
This is a list of pathogenic ClinVar variants found in the BACE2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-41168337-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
21-41168349-T-C | not specified | Uncertain significance (Jan 20, 2023) | ||
21-41168358-C-A | not specified | Uncertain significance (Mar 11, 2024) | ||
21-41168374-G-A | BACE2-related disorder | Benign (Jan 02, 2020) | ||
21-41168391-T-C | not specified | Likely benign (Apr 06, 2024) | ||
21-41168402-C-T | not specified | Uncertain significance (Mar 06, 2023) | ||
21-41168411-G-A | not specified | Uncertain significance (Feb 06, 2023) | ||
21-41168429-C-T | Benign (Aug 20, 2018) | |||
21-41168454-T-A | not specified | Uncertain significance (Jul 08, 2022) | ||
21-41168486-G-A | not specified | Uncertain significance (Mar 19, 2024) | ||
21-41168527-T-A | BACE2-related disorder | Likely benign (Jun 28, 2018) | ||
21-41168548-G-C | not specified | Uncertain significance (Nov 08, 2022) | ||
21-41179613-G-A | PLAC4-related disorder | Likely benign (Jun 15, 2022) | ||
21-41226315-C-T | not specified | Uncertain significance (Mar 29, 2023) | ||
21-41237544-G-C | not specified | Uncertain significance (Aug 02, 2021) | ||
21-41237600-C-T | Likely benign (Dec 31, 2019) | |||
21-41237682-A-G | not specified | Uncertain significance (Sep 25, 2023) | ||
21-41237710-C-G | not specified | Uncertain significance (Mar 14, 2023) | ||
21-41241895-T-C | not specified | Uncertain significance (Dec 21, 2023) | ||
21-41241931-C-T | not specified | Uncertain significance (Jul 14, 2021) | ||
21-41243366-C-T | BACE2-related disorder | Benign (Oct 30, 2019) | ||
21-41245968-G-A | not specified | Uncertain significance (Dec 07, 2021) | ||
21-41246053-G-A | not specified | Uncertain significance (Sep 15, 2021) | ||
21-41246055-G-A | not specified | Likely benign (Aug 11, 2022) | ||
21-41246062-T-C | not specified | Uncertain significance (Apr 12, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BACE2 | protein_coding | protein_coding | ENST00000330333 | 9 | 114718 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00676 | 0.990 | 125734 | 0 | 14 | 125748 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.60 | 201 | 276 | 0.729 | 0.0000165 | 3305 |
Missense in Polyphen | 73 | 129.88 | 0.56207 | 1535 | ||
Synonymous | 0.914 | 106 | 119 | 0.893 | 0.00000822 | 1104 |
Loss of Function | 2.56 | 7 | 19.1 | 0.367 | 8.97e-7 | 233 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000872 | 0.0000872 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000792 | 0.0000791 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Responsible for the proteolytic processing of the amyloid precursor protein (APP). Cleaves APP, between residues 690 and 691, leading to the generation and extracellular release of beta-cleaved soluble APP, and a corresponding cell-associated C- terminal fragment which is later released by gamma-secretase. It has also been shown that it can cleave APP between residues 671 and 672. {ECO:0000269|PubMed:10591213, ECO:0000269|PubMed:11083922, ECO:0000269|PubMed:11423558, ECO:0000269|PubMed:15857888, ECO:0000269|PubMed:16816112}.;
- Pathway
- Alzheimer,s disease - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.355
Intolerance Scores
- loftool
- 0.302
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 29.16
Haploinsufficiency Scores
- pHI
- 0.242
- hipred
- Y
- hipred_score
- 0.768
- ghis
- 0.511
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.637
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Bace2
- Phenotype
- cellular phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; pigmentation phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- bace2
- Affected structure
- myelinating Schwann cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- proteolysis;membrane protein ectodomain proteolysis;peptide hormone processing;protein catabolic process;glucose homeostasis;negative regulation of amyloid precursor protein biosynthetic process;astrocyte activation;amyloid-beta metabolic process
- Cellular component
- endosome;endoplasmic reticulum;Golgi apparatus;trans-Golgi network;plasma membrane;cell surface;membrane;integral component of membrane;dense core granule
- Molecular function
- amyloid-beta binding;aspartic-type endopeptidase activity